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Abstract
Proper localization of membrane proteins is essential for the function of biological membranes and 
for the establishment of organelle identity within a cell. Molecular machineries that mediate 
membrane protein biogenesis need to not only achieve a high degree of efficiency and accuracy, 
but also prevent off-pathway aggregation events that can be detrimental to cells. The 
posttranslational targeting of tail-anchored proteins (TAs) provides tractable model systems to 
probe these fundamental issues. Recent advances in understanding TA-targeting pathways reveal 
sophisticated molecular machineries that drive and regulate these processes. These findings also 
suggest how an interconnected network of targeting factors, cochaperones, and quality control 
machineries together ensures robust membrane protein biogenesis.
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OVERVIEW
Membrane proteins account for ~35% of the proteins encoded by the genome. The proper 
functioning of biological membranes requires all newly synthesized membrane proteins to 
be localized to and inserted into the appropriate membrane destinations. The process of 
membrane protein biogenesis presents several fundamental challenges for the cell. Given the 
multiple membranes in a eukaryotic cell, how are newly synthesized membrane proteins 
recognized and sorted to the correct target membranes? What are the energy requirements in 
these pathways? How are the hydrophobic transmembrane domains (TMDs) on nascent 
proteins effectively protected from aggregation as they traverse aqueous cellular 
environments? How are the TMDs efficiently inserted into the phospholipid bilayer? Finally, 
have cells evolved correction mechanisms for cases in which targeting and insertion fail?
The best-studied pathway for membrane protein targeting and insertion utilizes the signal 
recognition particle (SRP). SRP recognizes TMDs near the N terminus of nascent proteins 
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and delivers them to translocation machineries on the eukaryotic endoplasmic reticulum 
(ER) or the bacterial plasma membrane during translation; this cotranslational mode of 
targeting effectively minimizes the aggregation of membrane proteins in the cytosol 
(Akopian et al. 2013). Nevertheless, numerous membrane proteins cannot use SRP and must 
be targeted via posttranslational pathways, the mechanisms of which are far less well 
understood. A salient example is the class of tail-anchored proteins (TAs), which contain a 
single TMD near the C terminus. TAs compose 3–5% of the eukaryotic membrane proteome 
and mediate diverse cellular processes, including protein translocation across organelle 
membranes, vesicular transport, apoptosis, and protein quality control (Chartron etal. 2012a, 
Hegde & Keenan 2011). Because the C-terminal TMDs of TAs are obscured by the 
ribosome during translation, it was predicted early on that these proteins would be targeted 
by posttranslational mechanisms (Kutay et al. 1993). In support of this hypothesis, 
synaptobrevin 2 (Syb2), a tail-anchored SNARE protein, can be targeted to and inserted into 
the ER after release from the ribosome (Kutay et al. 1995). Recent work has uncovered 
multiple pathways that posttranslationally target TAs to different cellular membranes and 
has begun to elucidate the molecular mechanisms underlying these processes.
Studies of TA biogenesis have provided extensive information to help address how cellular 
machineries overcome multiple challenges during posttranslational membrane protein 
targeting. These studies begin to elucidate the nature of the targeting signals that direct TAs 
to diverse cellular membranes; the pathways, driving forces, and molecular mechanisms of 
their targeting; and the interconnection of the protein-targeting pathway with cellular 
chaperones and quality control machineries. Here, we summarize recent advances on these 
fronts from cell biological, genetic, structural, and biochemical studies.
TARGETING SIGNALS
Early microscopy studies of green fluorescent protein (GFP) fused to targeting sequences 
showed that C-terminal sequences encompassing the TMD are necessary for and sufficient 
to direct the proper localization of TAs to diverse organelles such as the ER, mitochondria, 
peroxisomes, and secretory membranes (Egan et al. 1999, Masaki et al. 2003, Mullen & 
Trelease 2000, Yagita et al. 2013). The notion of C-terminal TMDs as targeting signals, 
however, raises challenging questions as to how specific organelle information is encoded. 
The observation that Fission 1 (Fisl)-like proteins can localize to multiple organelles 
[mitochondria, peroxisomes, and chloroplasts (Ruberti et al. 2014)] highlights the 
promiscuity that could result from such degenerate topogenic signals.
Sequence comparisons and mutational analyses showed that the targeting information is 
encoded, in part, by a combination of physicochemical properties in the TMD (Figure 1). On 
average, TAs on the outer mitochondrial membrane (OMM) have shorter and less 
hydrophobic TMDs than do TAs that traffic to or through the ER (Figure 1) (Beilharz et al. 
2003, Lee et al. 2014, Rao et al. 2016). The TMDs of OMM TAs also exhibit lower helical 
contents than do the TMDs of ER-destined TAs (Rao et al. 2016). Proteins that harbor 
isoforms or splice variants that localize to either the ER or the OMM, such as cytochrome b5 
(Cytb5) and sarcolemmal membrane-associated protein (SLMAP), provided models for 
better-controlled analyses. In the cases of both Cytb5 and SLMAP, the TMD of the OMM 
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TA variant has lower hydrophobicity, and substitution of moderately hydrophobic residues 
with the more hydrophobic and helix-promoting leucine relocalized the variant to the ER 
(Byers et al. 2009, Hwang et al. 2004). Likewise, replacement of three glycines with 
leucines in the Fis1 TMD relocalized Fis1 from the OMM to the ER (Beilharz et al. 2003). 
Recently, hydrophobic residues in the TMD of Bos1, a vesicular TA, were systematically 
replaced with increasing numbers of alanine and glycine. Correlation analysis of this set of 
variants further showed that the helical propensity of the TMD plays an important role in 
engaging ER-targeting factors (Rao et al. 2016; see the section titled Substrate Selection by 
the GET Pathway, below). Thus, the hydrophobicity and helical propensity of the TMD 
together dictate TA localization to the ER versus other organelles.
Some mitochondrial TAs are enriched in basic residues immediately C terminal to the TMD; 
this positively charged C-terminal element (CTE) (Figure 1) is important for specifying the 
OMM localization of these TAs (Horie et al. 2002, Kuroda et al. 1998, Marty et al. 2014, 
Rao et al. 2016). Mutation of basic residues in the CTE of multiple OMM TAs reduced or 
abolished their mitochondria targeting and, in the cases of tung Cytb5 and Fis1, led to dual 
ER and mitochondria localization (Horie et al. 2002, Kuroda et al. 1998, Rao et al. 2016). A 
systematic variation of the CTE showed that a minimum of four basic residues is necessary 
and sufficient for specific mitochondrial localization of Fis1 (Rao etal. 2016). In addition, 
increasing the spacing between the TMD and basic CTE of TAs reduces their mitochondrial 
targeting (Horie et al. 2002, Marty et al. 2014), and bioinformatic analysis showed that a 
dibasic motif immediately following the TMD is a strong predictor of OMM TAs in plant 
cells (Marty et al. 2014). Intriguingly, the combination of a moderately hydrophobic TMD 
followed by a basic CTE also directs TAs to peroxisomes (Chen et al. 2014a, Halbach et al. 
2006, Yagita et al. 2013), although how mitochondrial and peroxisomal TAs are 
distinguished is unclear (Figure 1). Finally, the observation that insertion of leucines into the 
TMD of Fis1 overrides the CTE and allows for efficient ER targeting (Beilharz et al. 2003) 
indicates that TA localization is specified by a combination of physicochemical properties 
from both the TMD and the CTE.
The ER serves as the gateway from which proteins enter vesicular trafficking pathways to 
arrive at the Golgi apparatus, secretory granules, or the plasma membrane. Sequence 
analyses showed that, compared to ER-resident TAs, the TAs localized on secretory vesicles 
and the plasma membrane have longer and more hydrophobic TMDs (Pedrazzini et al. 1996, 
Rao et al. 2016). Consistent with this observation, lengthening the TMD of Cytb5 from 17 to 
22 amino acids led to recruitment of the mutant protein to ER exit sites and its export to the 
plasma membrane via the secretory pathway (Honsho et al. 1998, Pedrazzini et al. 1996, 
Ronchi et al. 2008). Although these observations need to be generalized to additional TAs, it 
is tempting to propose that the length and hydrophobicity of the TMD dictate whether TAs 
are retained in the ER or further enter vesicular trafficking (Figure 1).
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PATHWAYS AND MECHANISMS FOR TARGETING OF TAIL-ANCHORED 
PROTEINS
The GET Pathway for Targeting of Tail-Anchored Proteins to the ER
Much recent progress on TA biogenesis was driven by the discovery of the GET (guided 
entry of TA) pathway. The structure, dynamics, and interactions of GET components have 
been extensively characterized, providing the highest-resolution understanding of a TA-
targeting pathway thus far.
Summary of the pathway.—Early studies showed that TA insertion into the ER is ATP 
dependent and requires machineries distinct from those that mediate cotranslational protein 
targeting (Kutay et al. 1995). Subsequently, cross-linking studies in reticulocyte lysate 
identified a 40-kDa ATPase, TRC40, as a key targeting factor for TAs (Favaloro et al. 2008, 
Stefanovic & Hegde 2007). The yeast homolog of TRC40, Get3, was genetically linked to 
two integral membrane proteins on the ER, Get1 and Get2 (Schuldiner et al. 2005), which 
were shown to form the receptor complex for Get3 (Schuldiner et al. 2008). An additional 
protein complex, comprising Get4 and Get5, was found to participate in the pathway on the 
basis of the genetic interactions of Get4 and Get5 with Get1, Get2, and Get3; reduced TA 
targeting in Δget5 lysates; and the physical association of the Get4/5 complex with Get3 
(Jonikas et al. 2009). Biochemical reconstitutions showed that Get4/5 facilitates TA loading 
onto Get3 from the upstream cochaperone Sgt2 (Wang et al. 2010). Homologs or functional 
orthologs of all components of the yeast GET pathway have been identified in mammalian 
cells (Table 1) (Colombo et al. 2016; Mock et al. 2015; Vilardi et al. 2011, 2014; Xu et al. 
2012; Yamamoto & Sakisaka 2012). Collectively, these works define a conserved pathway in 
eukaryotic cells that mediates the targeted delivery and insertion of TAs into the ER.
This early work, together with subsequent mechanistic studies, defined the major molecular 
events in the GET pathway (Figure 2). After a nascent TA is synthesized and released from 
the ribosome, it is captured by Sgt2 through a yet unknown mechanism (step ➊). The 
Get4/5 complex, via its abilities to bridge between Sgt2 and Get3 and to regulate the 
conformation of Get3, stimulates the transfer of TA substrate from Sgt2 to ATP-bound Get3 
(step ➋). The Get3 •TA complex dissociates from Get4/5, and the TA substrate stimulates 
ATP hydrolysis on Get3 (step ➌). The Get3 •TA complex then engages the Get1/2 receptor 
complex at the ER membrane (step ➍), where Get1/2 releases TA from Get3 and facilitates 
TA insertion into the membrane (step ➎). Finally, Get3 is released from Get1 and is 
returned to the cytosol through binding of ATP and Get4/5 (step ➏). Our current 
understanding of the molecular mechanisms of these events is further discussed below.
Structure and function of Sgt2.—The most upstream factor identified thus far in the 
GET pathway is Sgt2, which captures TAs after their translation. Sgt2 contains multiple 
protein interaction domains: an N-terminal homodimerization domain (NTD) that binds 
Get5, a tetratricopep-tide repeat (TPR) domain that interacts with chaperones, and a 
glutamine-and methionine-rich C-terminal domain (CTD) (Figure 2). Immunoprecipitation 
experiments demonstrated that the Sgt2 CTD forms the substrate-binding site that selectively 
captures the TMDs of ER-destined TAs (Rao et al. 2016, Wang et al. 2010). The molecular 
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basis of this recognition is unclear but was speculated to be analogous to how the 
methionine-rich domain of SRP recognizes hydrophobic signal sequences in substrate 
proteins (Wang et al. 2010). As the individual domains of Sgt2 are connected by flexible 
linkers, the relative positions of these domains have not been defined. Small-angle X-ray 
scattering (SAXS) data suggested that the global conformation of Sgt2 is extended but likely 
flexible (Chartron et al. 2011), which raises possibilities of regulation by its diverse binding 
partners.
The Sgt2 NTD is both a homodimerization domain and interaction platform for the 
ubiquitin-like (UBL) domain of Get5, linking this cochaperone with the rest of the GET 
pathway (Chang et al. 2010, Chartron et al. 2010, Liou et al. 2007, Wanget al. 2010). 
Nuclear magnetic resonance (NMR) and crystallographic analyses of the Saccharomyces 
cerevisiae Sgt2 NTD bound to the Get5 UBL domain elucidated the molecular details of 
their interaction (Figure 2,Structure2)(Chartron et al. 2012b, Simon et al. 2013, Tung et al. 
2013). The Sgt2 homodimer interface is formed by a four-helix bundle, which is contributed 
by two N-terminal helices from each Sgt2 NTD and is stabilized by hydrophobic 
interactions. In contrast, the interaction of the Sgt2 NTD with the Get5 UBL domain is 
electrostatically driven. Conserved residues on the second helices of the Sgt2 NTD form an 
acidic surface that interacts with conserved basic and hydrophobic residues on a single Get5 
UBL domain via charge and shape complementarity (Figure 2, Structure 2). The Sgt2-Get5 
interaction is stable but occurs with fast association and dissociation kinetics (Chartron et al. 
2012b, Simon et al. 2013), which may allow Get4/5 to rapidly sample Sgt2 molecules.
Get4/5: a scaffold that bridges Sgt2 and Get3.—After capture by Sgt2, the TA 
substrate is transferred to Get3 in a Get4/5-dependent process (Wang et al. 2010). Get5 is a 
modular protein composed of an NTD that interacts with Get4, a UBL domain that binds the 
Sgt2 NTD as described above, and a CTD that mediates homodimerization (Figure 2, 
Structure 3) (Chartron etal. 2010). A minimal Get4/5N complex, formed between Get4 and 
the Get5NTD, was sufficient to recognize Get3 in a specific conformation and nucleotide 
state (Gristick et al. 2014, 2015) and was hence subjected to extensive biochemical and 
structural studies. Get4 forms an a2-solenoid fold composed of 14 right-handed helical coils 
(Bozkurt et al. 2010, Chang et al. 2010, Chartron et al. 2010). The N-terminal helix of Get5 
docks into a hydrophobic groove formed by helices α12 and α13 and the (β-tongue of Get4, 
forming an extremely stable Get4-Get5 interface (Chang et al. 2010, Chartron et al. 2010). 
On the other side of the Get4/5N complex, the N-terminal helices of Get4 provide a 
combination of acidic and hydrophobic residues to mediate interaction with Get3 (further 
discussed in the section titled The Get3 ATPase Cycle, below).
Multiple groups have reconstituted Get4/5-mediated stimulation of TA transfer from Sgt2 to 
Get3 (Mateja et al. 2015, Rao et al. 2016, Wang et al. 2010). Nevertheless, the precise 
mechanism(s) underlying the stimulatory effect of Get4/5 is not completely understood. By 
bringing Sgt2 and Get3 into close proximity, Get4/5 could enable a facile route for relay of a 
TA substrate while minimizing cytosolic exposure of the substrate TMD (Figure 2). In 
support of this model, the TA is protected from external traps during the transfer, and 
mutations disrupting the Sgt2-Get5 interaction resulted in significantly less TA transfer and 
less insertion-competent Get3•TA complexes (Mateja et al. 2015, Shao et al. 2017). As 
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discussed below in the section titled The Get3 ATPase Cycle, the Get4/5 complex also 
regulates the conformation of the Get3 ATPase, which could further promote substrate 
capture by Get3. It is also plausible that Get5 induces rearrangements in Sgt2 that facilitate 
TA release. The relative contributions of these mechanisms to the substrate handover event 
remain to be defined.
The Get5 CTD forms a stable dimer interface mediated by hydrophobic interactions 
(Chartron et al. 2012c). SAXS data also showed that Get4 and Get5 form an elongated 
heterotetramer (2:2) spanning 240 Å (see architecture of the heterotetrameric complete 
Get4/5 complex in Figure 2) (Chartron et al. 2010). Nevertheless, the functional relevance of 
Get5 homodimerization is unclear. The residues that mediate Get5 homodimerization are not 
conserved in its mammalian homolog (see UBL4A in Figure 5a, below). Furthermore, there 
appears to be an intriguing asymmetry in the Get4/5 complex such that only one copy of 
Get4 in this heterotetramer binds Get3 at physiological protein concentrations (Gristick et al. 
2015, Mateja et al. 2015). The mechanism of this asymmetric interaction and the 
evolutionary relevance of the Get5 homodimerization domain remain to be determined.
The Get3 ATPase cycle: Nucleotide-, effector-, and substrate-induced 
conformational changes drive the targeting pathway.—Central to the GET 
pathway is the ATPase Get3, which uses its ATPase cycle to capture and deliver TAs to the 
ER membrane (Favaloro et al. 2010, Stefanovic & Hegde 2007). Early crystallographic work 
showed that Get3 undergoes ATP-dependent rearrangements that can be coupled to substrate 
binding (Figure 3, step ➊). Get3 is an obligate homodimer bridged by a tightly coordinated 
Zn2+ ion. Each Get3 subunit contains a nucleotide hydrolase domain structurally and 
functionally coupled to a helical domain. Apo-Get3 crystallizes in an open conformation, in 
which the two helical domains are apart (Figure 3, Structure 1). In contrast, nonhydrolyzable 
ATP analogs induce readjustments at the dimer interface that bring the helical domains 
closer to one another (Figure 3, Structure 2) (Bozkurt et al. 2009, Hu et al. 2009, Mateja et 
al. 2009, Suloway et al. 2009). Importantly, closing of Get3 brings together conserved 
hydrophobic residues in the helical domains to form a hydrophobic groove that provides the 
binding site for the TA TMD (Mateja et al. 2015). Nevertheless, Get3 has been observed in a 
variety of conformations that differ in the degree of opening or closing, suggesting the 
presence of more than two defined states. Furthermore, molecular dynamics simulations 
suggest that Get3 dynamically samples multiple conformations (wide open, open, semiopen, 
semiclosed, and closed) in different nucleotide states (Wereszczynski & McCammon 2012). 
The number of conformational states in Get3 and how they are regulated by nucleotides 
remain to be defined.
Indeed, subsequent biochemical, enzymatic, and structural analyses uncovered additional 
con-formational states in Get3 that are regulated by the TA substrate and other GET 
components. A major regulator is the Get4/5 complex. Pulldown (Chartron et al. 2010, 
Gristick et al. 2014) and fluorescence (Rome et al. 2014) studies showed that Get4 
preferentially binds ATP-bound Get3, and reciprocally, Get4/5 stabilizes ATP binding to 
Get3 (Rome et al. 2013). As ATP stabilizes closed Get3, the synergy between ATP and 
Get4/5 in binding Get3 strongly suggests that Get4/5 also stabilizes Get3 in a closed 
conformation. In contrast, Get4/5 inhibits the ability of Get3 to hydrolyze ATP (Rome et al. 
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2013), suggesting that the global closing of Get3 can be uncoupled from catalytic activation 
at the ATPase site. This Get4/5-induced new state of Get3, termed occluded, was visualized 
crystallographically using Get4/5N bound to a hydrolysis-deficient mutant of Get3, Get3 
(D57V), loaded with ATP (Gristick etal. 2014). A single Get4 molecule bridges the Get3 
dimer interface and interacts with both subunits of Get3 (Figure 3, Structure 3). The 
interaction with one Get3 subunit consists of both electrostatic and hydrophobic contacts, 
generating an anchoring interface for high-affinity binding of Get4/5 to ATP-bound Get3 
(Gristick et al. 2014). Additional residues in Get4 establish a regulatory interface with the 
other Get3 subunit, at which a putative salt bridge between Get3 K69 and Get4 D74 is 
critical for ATPase inhibition (Gristick et al. 2014). Together, these results show that Get4/5 
primes Get3 into the optimal conformation and nucleotide state for capturing the TA 
substrate.
In contrast to Get4/5, a TA substrate induces a rapid round of ATP hydrolysis on Get3 
(Rome et al. 2013). This observation led to the proposal that the TA substrate induces Get3 
into an activated conformation and leads to the ATP hydrolysis event after TA loading on 
Get3 (Figure 3, steps ➌ and ➍). Upon TA loading, the interaction of Get3 with Get4/5 is 
weakened at least tenfold in the presence of ATP, and the interaction becomes undetectable 
with a nucleotide-free Get3•TA complex (Rome et al. 2014). These findings suggest that the 
TA substrate also helps drive the dissociation of Get3 from Get4/5. Finally, the TA substrate 
significantly slows nucleotide exchange on Get3. Compared to free Get3, ADP release from 
the Get3•TA complex is 200-fold slower, and ATP rebinding to the Get3•TA complex is 
10,000-fold slower and rate limited by a conformational change at physiological ATP 
concentrations (Rome et al. 2013). Slower nucleotide exchange provides extended time 
windows of ~14 and ~12 s for Get3•TA complexes in the ADP-bound and nucleotide-free 
states, respectively, during which these complexes can interact with the Get1/2 receptor 
complex (see the section titled The Get1/2 Membrane Receptor Complex Remodels the 
Targeting Complex, below).
The Get1/2 membrane receptor complex remodels the targeting complex.—
Get1/2 provides the receptor complex for the Get3•TA complex at the ER membrane 
(Schuldiner et al. 2008). Biochemical reconstitution with proteoliposomes validated that 
these two proteins (and their mammalian homologs) are necessary and sufficient for TA 
targeting and insertion (Mari-appan et al. 2011, Vilardi et al. 2014, F. Wang et al. 2011, 
Yamamoto & Sakisaka 2012). Both Getl and Get2 contain three predicted TMDs via which 
they assemble into a complex (Mari-appan et al. 2011, Wang et al. 2014). Both proteins also 
contain large cytosolic domains (CDs) (the N-terminal CD in Get2 and the TM1-TM2 loop 
in Get1) that interact with Get3. Get2 CD contains two amphiphilic helices connected by a 
glycine linker, and helix a1 electrostatically contacts one of the subunits in the Get3 dimer 
via conserved basic residues in the 14RERR motif (Mariappan et al. 2011, Stefer et al. 2011, 
F. Wang et al. 2011). Whereas the Get2 CD cocrystallized with closed, nucleotide-bound 
Get3 (Mariappan et al. 2011, Stefer et al. 2011), the Get1 CD cocrystallized with apo-Get3 
in the most open conformation observed thus far (Figure 3, Structure 5). The Get1 CD 
consists of two helices that form a coiled coil, which inserts like a wedge into the Get3 
dimer interface and contacts both Get3 subunits in the dimer (Kubota et al. 2012, Mariappan 
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et al. 2011, Stefer et al. 2011). Contacts with one Get3 subunit occur at its nucleotide-
binding domain, where an extensive interface is formed by both aromatic and charged 
residues. Contacts with the other Get3 subunit are smaller and involve helix α4 in its helical 
domain. Finally, Get1 and Get2 share overlapping interaction surfaces, notably the 
303DELYED motif on helix α11, on Get3 (Mariappan et al. 2011, Stefer et al. 2011). Both 
receptor subunits also share overlapping binding sites on Get3 with Get4/5 (Gristick et al. 
2014). Thus, these upstream and downstream GET proteins compete for interaction with 
Get3 during the targeting cycle.
These structural data, together with the following observations, strongly suggest that the 
Get3•TA complex is first captured by Get2 and then transferred to Get1. Get2 contains a 
>100-amino-acid linker that connects its Get3-binding helices to its TMDs, which may 
allow Get2 to search for Get3•TA complexes further away from the ER. Surface plasmon 
resonance (SPR) and fluorescence analyses show that the Get2 CD can bind Get3 and 
Get3•TA complexes in nucleotide-bound states, whereas the Get1 CD binds only the 
nucleotide-free Get3•TA complex and strongly prefers apo-Get3 in which the TA-binding 
groove is disrupted (Mariappan et al. 2011, Rome et al. 2014, Stefer et al. 2011). Finally, 
high concentrations of the Get1 CD can displace TA from Get3, whereas the Get2 CD 
cannot (Mariappan et al. 2011, F. Wang et al. 2011). To-gether, these results support a model 
in which the Get3•TA complex bound with ADP is initially recruited to the membrane by 
Get2; upon ADP release, the Get1 CD initiates interaction with and remodels the Get3•TA 
complex, leading to the release of TA from Get3 and to its insertion into the ER membrane 
(Figure 2, steps ➍ and ➎, and Figure 3, steps ➎ and ➏).
These data also predict that a stable complex between the Get1 CD and apo-Get3 
accumulates at the ER membrane at the end of the targeting cycle (Figure 2, end of step ➎). 
The tip of Get1 remodels both switch I and switch II loops at the Get3 ATPase site, inducing 
these loops into a conformation incompatible with nucleotide binding (Kubota et al. 2012, 
Mariappan et al. 2011, Stefer et al. 2011). Consistent with the structures, SPR and 
fluorescence measurements showed that ATP and the Get1 CD strongly antagonize one 
another for binding to Get3 (Kubota et al. 2012, Mariappan et al. 2011, Rome et al. 2014, 
Stefer et al. 2011). Furthermore, addition of ATP accelerated the release of Get3 from the 
Get1 CD and vice versa, suggesting a release mechanism involving active displacement 
(Kubota et al. 2012, Rome et al. 2014). Finally, with full-length Get1/2 proteoliposomes or 
ER microsomes, Get4/5 was also needed to promote the facile release of Get3 from the 
membrane (Rome et al. 2014). Thus, the recycling of Get3 in the GET pathway is an 
elaborate event driven by both ATP and Get4/5 (Figure 2, step ➏).
Despite extensive progress, multiple questions remain for the GET pathway. First, the 
structural basis for the TA-induced changes in Get3 activity is unclear. Although a cocrystal 
structure of Get3 (D57N) bound to a TMD peptide (Mateja et al. 2015) is available, the 
conformation of Get3 in this structure is similar to the conformations in the Get3•Get4/5 
complex and in ADP•AlF4-bound Get3. The structure, dynamics, and mechanism of 
regulation of the Get3•TA complex remain to be elucidated at the molecular level (Figure 3, 
question marks). In addition, the structures of important intermediates in the pathway, such 
as Get2 and/or Get1 bound to the Get3•TA complex, are still unavailable. Whether Get2 acts 
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passively to bring the Get3•TA complex to Get1 or plays a more active role is unclear. 
Although Get1 and Get2 bind at overlapping sites on Get3, their cobinding has been 
observed by NMR (Stefer et al. 2011); the stoichiometry and relationship of the interaction 
of Get3•TA with full-length Get1/2 remain to be resolved. Finally, the molecular 
mechanisms by which Get1/2 inserts the TA into the membrane are still unclear (see further 
discussion in the section titled Outstanding Questions, below).
Substrate selection by the GET pathway.—The GET pathway provides an 
opportunity to decipher the mechanism by which targeting machineries specifically select 
TAs destined to the appropriate organelle. Systematic variation of the targeting sequence in 
model TAs, coupled with biochemical dissections, revealed at least two selection filters that 
distinguish GET-dependent from GET-independent substrates (Rao et al. 2016). First, Sgt2 
preferentially binds TMDs that have higher hydrophobicity and helical content, a preference 
that is paralleled by Get3. After TAs are loaded onto Get3, substrates containing a highly 
basic CTE (which characterizes mitochondrial TAs; see the section titled Targeting Signals, 
above) are inserted more slowly into the ER membrane and are thus more likely to partition 
into off-pathway processes, such as dissociation from Get3 and aggregation in the cytosol 
(Rao et al. 2016). As this second selection occurs after ATP hydrolysis by the Get3^TA 
complex, it provides a mechanism akin to kinetic proofreading during tRNA selection by the 
ribosome (Rodnina & Wintermeyer 2001). Additional mechanisms, such as competition by 
other cellular chaperones and quality control machineries, could further enhance the 
selectivity of the GET pathway; these possibilities remain to be explored.
Alternative Pathways of Targeting Tail-Anchored Proteins to the ER
In addition to the GET pathway, there is strong evidence for other pathways that deliver TAs 
to the ER. In yeast lysate, TA variants containing a Fis1 TMD insert into ER microsomes 
independently of Get3 (Rao et al. 2016). The ER localization of Cytb5 is independent of 
GET components in mammalian cells (Favaloro et al. 2008, 2010). In vitro, purified Cytb5 
and protein tyrosine phosphatase 1B are targeted and inserted into liposomes independently 
of protein or nucleotides (Brambillasca et al. 2005, 2006; Colombo et al. 2009). Despite 
these apparently spontaneous reactions, Cytb5 associates with protein factors, including 
Hsc70, in lysates (Colombo et al. 2009). Given the propensity of TMDs to aggregate in the 
crowded cytosolic environment, newly synthesized TAs probably associate with cellular 
chaperones even if their TMDs are moderately hydrophobic. Whether chaperone functions 
are important for the targeting of these TAs, whether TA targeting in vivo requires additional 
protein factors, and the number of TAs utilizing these alternative pathways remain open 
questions.
The recently discovered SRP-independent (SND) proteins likely provide redundant routes 
for TA targeting to the ER (Aviram et al. 2016). A high-content screen in S. cerevisiae 
identified three proteins, Snd1, Snd2, and Snd3, whose deletions are synthetically lethal with 
deletion of Get3 or Get1, suggesting that the SND and GET components provide redundant 
functions in yeast cells. Furthermore, overexpression of SND proteins partially rescues the 
loss of SRP components, suggesting that SND proteins also provide a backup pathway(s) for 
the targeting of some SRP-dependent substrates. Notably, proximity ribosome profiling and 
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variation of the TMD position in reporter proteins showed that the SND proteins have the 
largest impact on substrates whose TMDs reside at neither the N nor the C terminus. These 
results suggest that the SRP, SND, and GET components provide partially redundant routes 
for the targeting of a broad range of membrane proteins, and together these targeting factors 
provide a robust, interlinked network of pathways for delivering proteins to the ER in yeast 
cells.
Localization of Tail-Anchored Proteins to Peroxisomes
Analogous to other peroxisomal membrane proteins, TAs are targeted to peroxisomes via 
one of two pathways: direct targeting from the cytosol or trafficking through the ER (Figure 
4). Both pathways are dependent on two targeting factors, the cytosolic Pex19 and its 
membrane receptor Pex3, which are crucial for peroxisomal biogenesis. Pex19 contains an 
NTD rich in intrinsically disordered segments and a helical CTD (Hattula et al. 2014, 
Schueller et al. 2010). Pex3 contains a short N-terminal sequence, a single TMD, and a 
cytosolic CTD that forms a twisted six-helix bundle (Figure 4, Structure 1). A peptide 
corresponding to the N-terminal segment of Pex19 docks into a hydrophobic groove at the 
membrane-distal end of the Pex3 CD (Figure 4, Structure 1) (Sato et al. 2010, Schmidt et al. 
2010). Conserved leucines and aromatic residues in this segment are important for Pex3 
binding and peroxisomal biogenesis (Sato et al. 2010). In addition, hydrogen/deuterium 
exchange experiments showed that the C terminus of Pex19 became more protected upon 
Pex3 binding, suggesting a conformational change at this site (Hattula et al. 2014). As the 
Pex19 CTD contains its substrate recognition site, the Pex3-induced rearrangement could 
regulate substrate binding; this hypothesis remains to be tested.
The import of peroxisomal membrane proteins via the ER-dependent pathway (Figure 4, 
right path) was more extensively studied in yeast cells. Microscopy analyses showed that a 
subset of peroxisomal TAs, including yeast Pex15 and plant ascorbate peroxidase, are first 
targeted to the ER by the GET machinery (Lisenbee et al. 2003, Mullen & Trelease 2000, 
Schuldiner et al. 2008, van der Zand et al. 2010). Exit of Pex15 from the ER involves the 
formation of a specialized subdomain in the ER membrane, termed peroxisomal ER, 
followed by budding of preperoxisomal vesicles from this region and fusion of the vesicle 
with existing peroxisomes (Smith & Aitchison 2013). Microscopy studies and in vitro 
budding assays showed that generation of preperoxisomal vesicles from the ER requires 
Pex3 and Pex19, ATP, and unidentified cytosolic factors (Lam et al. 2010, van der Zand et al. 
2010). Studies on other peroxisomal membrane proteins showed that Pex3 plays two 
important roles in the post-ER processes. First, its luminal sequence provides the signal that 
sorts Pex3 to peroxisomal ER. Second, its TMD is required for subsequent transport of the 
vesicle to existing peroxisomes (Fakieh et al. 2013). Whether these lessons pertain to 
peroxisomal TAs remains to be determined.
A mammalian TA, PEX26, is directly targeted from the cytosol to peroxisomes and is thus a 
model substrate for investigations of this pathway (Figure 4, left path). PEX26 is first 
captured by Pex19, which recognizes both the TMD and basic CTE on the TA and maintains 
its solubility in the cytosol (Chen et al. 2014a, Halbach et al. 2006, Yagita et al. 2013). The 
helical CTD of Neurospora crassa Pex19is sufficient to prevent PEX26 aggregation (Chen et 
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al. 2014a), suggesting that the Pex19 CTD contains the substrate-binding site. PEX26is 
delivered to peroxisomes via the interaction of Pex19 with Pex3 (Chen et al. 2014a, Yagita et 
al. 2013). Biochemical reconstitutions further identified two elements in the targeting 
complex, an amphiphilic segment adjacent to the Pex19 helical domain and a membrane-
proximal hydrophobic surface on Pex3, that are important for the subsequent membrane 
insertion of PEX26 (Chen et al. 2014a). It was speculated that a sequential handoff of the 
TMD, from the Pex19 helical domain to the Pex3 membrane-proximal and finally to the 
lipid bilayer, provides a pathway for the insertion of PEX26 into the peroxisomal membrane 
(Chen et al. 2014a). This hypothesis and its mechanistic details remain to be studied.
CONNECTION OF TAIL-ANCHORED PROTEIN TARGETING TO QUALITY 
CONTROL MACHINERIES
The BAG6 Complex Directs Membrane Proteins to the Ubiquitin-Proteasome Pathway
Protein targeting and translocation are not perfectly efficient, which necessitates degradation 
mechanisms to clear membrane proteins inappropriately exposed in the cytosol. In 
mammalian cells, the homologs of Sgt2 (SGTA) and Get3 (TRC40) are physically linked to 
a multifunctional BAG6 (BCL2-associated athanogene) complex, which could both enhance 
TA loading onto TRC40 (Mariappan et al. 2010) and direct mislocalized membrane proteins 
to quality control machineries (Hessa et al. 2011). The heterotrimeric BAG6 complex 
comprises BAG6 bound to TRC35 and UBL4A, the mammalian homologs of Get4 and 
Get5, respectively (Figure 5a). Analogous to their yeast homologs, the SGTA NTD 
recognizes the UBL domain of UBL4A (Figure 5a) (Darby et al. 2014, Xu et al. 2012). 
Nevertheless, UBL4A lacks residues in the Get5 CTD that mediates homodimerization and 
instead forms a heterodimer with the C-terminal helices of BAG6 (Figure 5a, Structure 1) 
(Mock et al. 2015). TRC35 also lacks the β-loop involved in the Get4-Get5 interface and 
instead binds to the BAG6 nuclear localization sequence (NLS) (Figure 5a) (Mock et al. 
2015). Biochemical reconstitutions showed that a minimal BAG6 fragment containing its C-
terminal helices and NLS is sufficient to stimulate TA transfer from SGTA to TRC40 (Mock 
et al. 2015, Shao et al. 2017), mimicking the function of yeast Get4/5 in enhancing TA 
transfer from Sgt2 to Get3. In addition to participating in the GET pathway, recombinant 
BAG6 can cross-link to and chaperone substrate proteins that expose hydrophobic sequences 
(Rodrigo-Brenni et al. 2014, Q. Wang et al. 2011). Moreover, an N-terminal UBL domain of 
BAG6 (Figure 5a, Structure 2) recruits the ubiquitin ligase RNF126, which mediates 
polyubiq-uitylation of client proteins for degradation by the proteasome (Rodrigo-Brenni et 
al. 2014). The BAG6 complex appears to provide a general quality control complex for 
mislocalized proteins, including membrane proteins inappropriately exposed in the cytosol 
and retrotranslocated proteins en route to ER-associated degradation (Hessa et al. 2011, Q. 
Wang et al. 2011).
Intriguingly, the UBL domains of BAG6 and UBL4A recognize the same interaction surface 
on SGTA (Darby et al. 2014, Leznicki et al. 2013). Thus, TAs bound to SGTA have two 
potential fates: transfer to TRC40 for targeting to the ER and transfer to BAG6 for 
ubiquitylation and degradation (Figure 5a). The two paths compete with one another in vitro 
and in vivo, but transfer toTRC40 appears to dominate under physiological conditions 
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(Leznicki & High 2012, Shao etal. 2017, Wunderley et al. 2014). In addition to BAG6, 
SGTA has emerged as a key regulator in protein quality control, as its TPR domain also 
interacts with heat-shock proteins (Scheufler et al. 2000), the proteasome-associated 
ubiquitin receptor Rpn13 (Leznicki et al. 2015, Thapaliya et al. 2016), and a variety of 
hormone receptors. Many molecular details of the SGTA-BAG6 cycle remain to be 
understood, including how SGTA and BAG6 distinguish newly synthesized proteins from 
mislocalized proteins, what dictates the partition of substrate proteins between the targeting 
and degradation pathways, and how SGTA participates in additional quality control 
pathways.
AAA-ATPases Promote Degradation of Tail-Anchored Proteins Mislocalized to 
Mitochondria
In addition to the cytosolic BAG6 complex, cells have evolved degradation machineries to 
clear mistargeted TAs. Using ER-and peroxisome-destined Pex15 and Gos1 as model TAs, 
two recent studies found thatMsp1 (or human ATAD1)—a conserved AAA-ATPase (an 
ATPase associated with a variety of cellular activities) anchored on the OMM—is essential 
for sensing and degrading TAs mistargeted to mitochondria in yeast and mammalian cells. 
When the GET pathway is impaired, loss ofMsp1 results in accumulation of Pex15 and 
Gos1 on mitochondria, severe mitochondrial damage, and severe cell growth defects (Chen 
et al. 2014b, Okreglak & Walter 2014). Msp1 also associates with and enhances the 
degradation of a Pex15 variant misdirected to the OMM (Okreglak & Walter 2014). These 
findings suggest that, in addition to protein-targeting machineries, Msp1 and potentially 
other machineries provide local surveillance and quality control mechanisms to further 
enhance the fidelity of TA localization to specific organelles (Figure 5b).
OUTSTANDING QUESTIONS
Mechanism of Insertion of Tail-Anchored Proteins at the Membrane
How TAs insert into biological membranes is not well understood. Even basic questions, 
such as whether insertion occurs spontaneously or is protein assisted, remain unclear. This 
situation differs from that of polytopic membrane proteins and proteins with a TMD near the 
N terminus, whose insertion is strongly dependent on translocation complexes such as 
Sec61p (or SecYEG in bacteria) and/or the YidC/Oxa1/Alb3 family of translocases (Dalbey 
& Kuhn 2014, Rapoport 2007). In contrast, TAs with moderately hydrophobic TMDs can 
insert into protein-free liposomes, as described above (see the section titled Alternative 
Pathways of Targeting Tail-Anchored Proteins to the ER), and surprisingly long domains 
ofvarious sequences (up to 85 residues) and charges that are C terminal to the TMD can be 
translocated in these apparently unassisted insertion reactions (Brambillasca et al. 2006, 
Sakamoto et al. 2012). That more hydrophobic TMDs could not be inserted in this 
mechanism was attributed to their aggregation in solution (Brambillasca et al. 2006). These 
in vitro experiments suggest that, if a TA is maintained in a soluble, translocation-competent 
state, its spontaneous insertion into membrane can be efficient and stable. Nevertheless, the 
structure and dynamics of biological membranes are strongly affected by the proteins 
embedded in or associated with them, and whether spontaneous TA insertion occurs in vivo 
is unclear.
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The GET pathway provides an example wherein the insertion of a single TMD into the lipid 
bilayer requires facilitation by membrane-embedded protein factors. Mutation of each TMD 
in a covalently linked Get1-Get2 construct disrupted TA insertion both in vitro and in vivo 
without affecting the function of the Get1/2 CDs (Wang et al. 2014). In addition, cross-links 
were observed between the TMDs of Get1 and the TMD of the model TA Sec22, suggesting 
a potential TA docking site formed by the TMDs of Get1/2 (Wang et al. 2014). Nevertheless, 
how the Get1/2 complex facilitates TA insertion into membrane is the least understood 
aspect of the GET pathway. Many questions remain to be addressed, including the site(s) for 
TA docking in the Get1/2 receptor, the conformation and orientation of TA when bound at 
the translocase site, and the pathway by which the substrate TMD accesses and integrates 
into the lipid bilayer.
Connection of Tail-Anchored Protein-Targeting Pathways with Cellular Chaperones
Both Get3 and Sgt2 (and their mammalian homologs) contain well-defined sites for binding 
hydrophobic TMDs, and their binding is critical for shielding TAs from the cytosol during 
targeting. Nevertheless, whether these factors are sufficient for the efficient capture and 
chaperoning of TAs, and the mechanism by which TAs are loaded onto Sgt2 (or SGTA), 
remains unclear. Although earlier work observed associations of Get4/5 and the BAG6 
complex with ribosomes (Fleischer et al. 2006, Mariappan et al. 2010), the causal 
relationship between these putative ribosome interactions and TA loading onto Sgt2 has not 
been established. Further confounding this question is the association of Sgt2 (or SGTA) 
with molecular chaperones. In yeast lysate, Sgt2 coimmunoprecipitates with members of 
multiple chaperone families, including Hsp70, Hsp90, Hsp100, and Ybr137w(Chartron et al. 
2011, Liou et al. 2007, Wanget al. 2010). Analogous chaperone interactions were observed 
with mammalian SGTA (Roberts et al. 2015). The chaperone interaction site was mapped to 
the Sgt2 TPR domain, in which a dicarboxylate clamp binds the charged C-terminal tails of 
different chaperones (Figure 2, Structure 1) (Chartron et al. 2011, Wang et al. 2010). Despite 
this structural information, the involvement of chaperones in TA targeting is unclear. Early 
work found that TAs associate with Hsp40/Hsc70 in cell lysates (Abell et al. 2007), and 
supplementing Hsc70 enhanced the efficiency of TA targeting to the ER in reconstituted 
reactions (Rabu et al. 2008). Hsp70 also associates with mitochondrial TAs (Wang et al. 
2010) and with Cytb5 (Colombo et al. 2009), which are targeted to the ER independently of 
GET components. The precise roles of Hsp/Hsc70 chaperones in TA targeting remain to be 
understood.
Targeting of Tail-Anchored Proteins to Mitochondria and Chloroplasts
The mechanism by which TAs are selectively targeted to mitochondria remains unknown. 
The targeting and insertion of several OMM TAs have been examined and exhibited no 
dependencies on nucleotides, electrochemical potential, or components of the translocase on 
the OMM (Kemper et al. 2008, Setoguchi et al. 2006). Intriguingly, the targeting of Bak and 
Bcl-XL, two OMM TAs with roles in apoptosis, is dependent on cytosolic factors in the cell 
lysate, but this requirement could be bypassed when a well-folded GFP was fused to the 
targeting sequences of these proteins (Setoguchi et al. 2006). This finding led to the 
hypothesis that OMM TAs require chaperones, depending on the folding competence of 
their CDs, but a chaperone requirement for the C-terminal TMD has not been established. 
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The only exceptions are Tom5, whose targeting was compromised by knockdown of Tom40, 
and Bak, whose targeting depends on its binding partner, VDAC2, on the OMM (Setoguchi 
et al. 2006). Dedicated factors that provide a common pathway for the targeted delivery of 
OMM TAs remain to be identified. In the absence of this information, whether the targeting 
of OMM TAs is spontaneous or protein assisted cannot be resolved.
Chloroplasts contain at least eight identified TAs, but the targeting of only a few of these has 
been characterized (Dhanoa et al. 2010, Lee et al. 2014). Among these TAs are two GTPases 
that compose the translocase on the outer chloroplast membrane, Toc33 and Toc34, and an 
outer envelope protein, OEP9. All three proteins require the Arabidopsis ankyrin repeat-
containing protein ARK2A for specific targeting to chloroplasts (Dhanoa et al. 2010). 
ARK2Ais an essential cytosolic factor for OEP biogenesis; pulldown studies and 
localization assays showed that it acts as a chaperone to prevent the aggregation of a variety 
of nascent OEPs in the cytosol and facilitates their targeting to chloroplasts (Bae et al. 
2008). Whereas the TMD and CTE of OEP9 are sufficient to direct its localization (Dhanoa 
et al. 2010), the targeting of Toc33 andToc34 also requires their cytosolic GTPase domains. 
In addition, OEP9 requires different protein factors on the chloroplast membrane for 
integration relative to Toc33 and Toc34 (Dhanoa et al. 2010). These observations suggest 
that at least two protein-assisted pathways mediate the targeting and insertion of TAs into 
chloroplasts. The components and molecular events involved in these pathways remain to be 
defined.
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SUMMARY POINTS
1. A combination of physicochemical properties in the transmembrane domain 
and C-terminal elements dictates TA sorting to different organelles.
2. A cascade of protein interactions in the GET pathway mediates TA targeting 
and insertion into the ER.
3. Nucleotide-, substrate-, and effector-driven conformational changes during 
the Get3 ATPase cycle drive TA targeting in the GET pathway.
4. Two distinct pathways mediate TA localization to peroxisomes.
5. Quality control machineries in the cytosol and on mitochondria provide 
clearance mechanisms for mislocalized membrane proteins.
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FUTURE ISSUES
1. How are TAs inserted into biological membranes?
2. How are posttranslational membrane protein-targeting pathways linked to the 
cellular chaperone network?
3. How are TAs targeted to mitochondria and chloroplasts?
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Figure 1. 
A combination of physicochemical properties in the transmembrane domain (TMD) and C-
terminal element (CTE) directs tail-anchored proteins (TAs) to distinct cellular organelles. 
TAs with weakly hydrophobic TMDs or those with a moderately hydrophobic TMD 
followed by a basic CTE are targeted to mitochondria or peroxisomes. TAs with moderately 
to strongly hydrophobic TMDs are targeted to the ER. TAs with long and strongly 
hydrophobic TMDs further enter vesicular trafficking pathways to reach secretory vesicles, 
the Golgi apparatus, and the plasma membrane.
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Figure 2. 
Major steps in the yeast GET pathway. (➊) A nascent tail-anchored protein (TA) is captured 
by Sgt2 after translation by the ribosome. Structure 1 (PDB 3SZ7) shows the Sgt2 
tetratricopeptide repeat (TPR) domain, which binds various chaperones. (➋) Sgt2 transfers 
the TA to Get3, a process stimulated by the Get4/5 complex. Structure 2 (PDB 2LXC) shows 
the N-terminal domain of Sgt2 bound to the ubiquitin-like (UBL) domain of Get5. (➌) The 
Get3•TA complex dissociates from Get4/5, and ATP hydrolysis is activated. (➍) The Get2 
subunit in the Get1/2 receptor captures the Get3•TA complex. (➎) Following ADP release, 
Getl interacts with and disassembles the Get3•TA complex, and the TAis inserted into the 
membrane through an unknown mechanism. (➏) ATP and Get4/5 together drive the release 
of Get3 from Getl, recycling Get3 for additional rounds of targeting. Structure 3 (PDB 
2LNZ) shows the Get5 homodimerization domain. TMD denotes transmembrane domain. 
Individual proteins are denoted by the following colors: Getl, cyan; Get2, violet; Get3, 
yellow; Get4, orange; Get5, red; Sgt2, blue; TA, green.
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Figure 3. 
The Get3 ATPase cycle is driven by nucleotides, effectors, and tail-anchored protein (TA) 
substrates. Structure 1 shows apo-Get3 in an open conformation (PDB 3H84), although 
whether this species exists in vivo is unclear. (➊) ATP binding induces Get3 into a closed 
conformation (Structure 2; PDB 2WOJ). (➋) Get4/5 preferentially binds closed Get3 and 
inhibits its ATPase activity, generating an occluded state (Structure 3; PDB 4PWX). (➌) TA 
binding induces Get3 into an activated state, and Get3 dissociates from Get4/5. The crystal 
structure of Get3 bound with a transmembrane domain (TMD) peptide is shown in Structure 
4 (PDB 4XTR), although the structural basis for the TA-induced activation of Get3 is 
unclear. (➍) Activated Get3 hydrolyzes ATP, and the ADP-bound Get3TA complex can 
bind Get2. (➎) ADP release induces additional rearrangements in the Get3 •TA complex, 
which enable it to interact with Get1. (➏) The strong preference of Get1 for a wide-open 
Get3 (Structure 5; PDB 3SJB) drives the release of TA from Get3. CD denotes cytosolic 
domain. The two subunits in the Get3 homodimer are in blue and tan in all structures.
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Figure 4. 
Two distinct pathways target tail-anchored proteins to peroxisomes. In the direct pathway 
(left path), Pex19 captures PEX26 in the cytosol and delivers it to peroxisomes via 
interaction with Pex3. PEX26 is then inserted into the peroxisomal membrane via an 
unknown mechanism. In the ER-dependent pathway (right path), Pex15 is first targeted to 
the ER membrane and is then sorted to peroxisomal ER. Exit of Pex15 from the ER occurs 
via budding of preperoxisomal vesicles that eventually fuse with peroxisomes, and this 
process requires Pex3 and Pex19. Structure 1 (PDB 3AJB) shows the crystal structure of the 
Pex3 cytosolic domain bound to the Pex19 N-terminal peptide.
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Figure 5. 
Connection of tail-anchored protein (TA) targeting to quality control pathways. (a) 
Architecture of the mammalian TA transfer complex, in which SGTA and TRC40 are linked 
by the heterotrimeric BAG6 complex comprising UBL4A, TRC35, and BAG6. Dashed lines 
depict the two potential fates of the TA in this complex: transfer to TRC40 for targeting to 
the ER and transfer to BAG6 for ubiquitylation and degradation. Structure 1 (PDB 4WWR) 
shows the crystal structure of the complex between the C-terminal helices of UBL4A and 
BAG6. Structure 2 (PDB 4DWF) shows the crystal structure of the N-terminal UBL domain 
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of BAG6. (b) A local quality control mechanism at mitochondria based on the AAA-ATPase 
Mspl on the outer mitochondrial membrane, which degrades Pex15 mislocalized to 
mitochondria when the GET pathway is disabled. Other abbreviations: NLS, nuclear 
localization sequence; UBL, ubiquitin like.
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Table 1
Components of the GET pathway in yeast and mammalian cells
Cell type
Upstream
cochaperone Scaffolding complex Cytosolic ATPase Membrane receptors
Yeast Sgt2 Get4/5 Get3 Getl Get2
Mammal SGTA TRC35/UBL4A/BAG6 TRC40 WRB CAML
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